ALHC — Alignment Healthcare, Inc. stock price, charts and financials

QT29Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (NASDAQ: ALHC) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.35
-0.35-4.02%
OverviewShort InterestFilings
ALHCQT29Alignment Healthcare, Inc.·NASDAQ
8.35-4.02%
News
Down 4.0% — Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm (globenewswire.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Insider selling clusterHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
PGNY+0.44%$27.13CLOV-1.76%$4.46OSCR+0.47%$32.13MOH-2.10%$200.79CNC-2.97%$65.11HUM+0.44%$386.22CI-0.26%$275.28ELV-0.80%$410.95
Snapshot
Index-P/E43.95EPS (ttm)0.19Insider Own-Shs Outstand207.44MPerf Week-33.78%
Market Cap1.73BForward P/E19.25EPS next Y0.43Insider Trans-0.98%Shs Float187.52MPerf Month-34.66%
Enterprise Value1.36BPEG0.58EPS next Q-0.02Inst Own-Short Float12.18%Perf Quarter-61.80%
Income41.00MP/S0.38EPS this Y-4.44%Inst Trans-Short Ratio4.08Perf Half Y-54.02%
Sales4.58BP/B6.54EPS next Y138.87%ROA3.18%Short Interest22.84MPerf YTD-57.72%
Book/sh1.28P/C2.47EPS next 5Y75.18%ROE20.02%52W High25.12 -66.76%Perf Year-49.94%
Cash/sh3.38P/FCF12.73EPS past 3/5Y-ROIC9.23%52W Low8.27 0.97%Perf 3Y55.20%
Dividend Est.-EV/EBITDA15.63Sales past 3/5Y40.17% 32.72%Gross Margin12.55%Volatility12.37% 6.00%Perf 5Y-55.49%
Dividend TTM-EV/Sales0.30EPS Y/Y TTM128.36%Oper. Margin1.20%ATR (14)0.92Perf 10Y-
Dividend Ex-Date-Quick Ratio1.70Sales Y/Y TTM69.30%Profit Margin0.89%RSI (14)16.63Recom2.13
Dividend Gr. 3/5Y-Current Ratio1.70EPS Q/Q142.86%SMA20-33.16%Beta1.13Target Price19.00
Payout0.00%Debt/Eq1.84Sales Q/Q31.63%SMA50-44.65%Rel Volume3.72Prev Close8.70
Employees1,849LT Debt/Eq1.84EarningsOct 29SMA200-55.08%Avg Volume6.34MPrice8.35
IPO DateMar 26, 2021Option/ShortYes / YesEPS/Sales Surpr.31.75% 1.96%Net Debt/EBITDA-4.20Volume23,581,333Change-4.02%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-03-26DowngradeRaymond JamesStrong Buy → Outperform$22 → $19
May-26-26ReiteratedBarclaysEqual Weight$19 → $16
May-07-26ReiteratedRaymond JamesStrong Buy$27 → $22
May-01-26ReiteratedBarclaysEqual Weight$18 → $19
May-01-26ReiteratedUBSNeutral$21 → $22
Jan-30-26ReiteratedRobert W. Baird$22 → $28
Jan-22-26ReiteratedKeyBancOverweight$21 → $28
Jan-14-26ReiteratedUBSNeutral$18 → $21
Jan-06-26ReiteratedPiper SandlerOverweight$21 → $30
Nov-24-25UpgradeJP MorganNeutral → Overweight
Latest News· Times ET
Sep-17-26
Sep-17-2607:00AM
Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firmglobenewswire.com
05:00AM
Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigationglobenewswire.com
Sep-16-26
Sep-16-2601:33PM
ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosuresglobenewswire.com
01:13PM
Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruzglobenewswire.com
12:32AM
Alignment Healthcare (NASDAQ:ALHC) Reaches New 52-Week Low – What’s Next?defenseworld.net
Sep-15-26
Sep-15-2606:55PM
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To KnowYahoo
03:00PM
Rosen Law Firm Encourages Alignment Healthcare, Inc. Investors to Inquire About Securities Class Action Investigation - ALHCbusinesswire.com
Sep-14-26
Sep-14-2605:45AM
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors With Losses to Learn More About the Investigationglobenewswire.com
Sep-13-26
Sep-13-2612:13AM
John Kao Sells 385,270 Shares of Alignment Healthcare (NASDAQ:ALHC) Stockdefenseworld.net
Sep-10-26
Sep-10-2604:00AM
Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widenglobenewswire.com
Sep-09-26
Sep-09-2611:45AM
Kaplan Fox Reminds Alignment Healthcare, Inc. (ALHC) Investors of an Investigation into Potential Securities Law Violationsnewsfilecorp.com
06:30AM
Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Protect Their Rights Amid a Securities Investigationglobenewswire.com
Sep-08-26
Sep-08-2611:30AM
Kaplan Fox & Kilsheimer LLP Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violationsnewsfilecorp.com
07:00AM
Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniorsglobenewswire.com
Sep-04-26
Sep-04-2603:02PM
Alignment Healthcare (ALHC): Buy, Sell, or Hold Post Q2 Earnings?Yahoo
Company

Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue4,5783,9492,704—————
Cost of Goods Sold Incl. D&A4,0033,4602,407—————
Gross Profit574489297—————
Selling, General and Administrative Excl. Other2520371—————
Research and Development
000—————
Other Operating Expense26847427—————
Operating Income5615-102—————
Interest Expense161624—————
Unusual Expense
————————
Non-Operating Income (Expense)00-3—————
Net Income Before Taxes39-1-128—————
Income Taxes
-200—————
Consolidated Net Income41-1-128—————
Net Income From Continuing Operations41-1-128—————
Net Income41-1-128—————
EPS (Recurring)0.20-0.00-0.67—————
EPS (Basic, Before Extraordinaries)0.20-0.00-0.67—————
EPS (Diluted)0.19-0.00-0.67—————
EBITDA8745-77—————
Other After Tax Adjustments
————————
Stock Option Compensation Expense
————————
Price To Earnings Ratio
43.95———————
Price To Sales Ratio0.380.990.79—————
Gross Margin12.5412.3810.98—————
Operating Margin1.220.38-3.77—————
Net Margin0.90-0.03-4.73—————
Shares Outstanding207198191—————
Market Capitalization1,7283,9112,149—————
Operating Lease Expense
————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$26.99$21.72$16.45$11.19$5.92● Close Price0.00M161.25M322.49M483.74M644.99MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
KONOWIECKI JOSEPH SEVP, Corporate AffairsSep 17 '26Sale8.6123,511202,4301,080,305Sep 18
KAO JOHN EChief Executive OfficerSep 14 '26Sale13.0027,400356,200590,766Sep 16
KAO JOHN EChief Executive OfficerSep 11 '26Sale12.68385,2704,885,2241,223,473Sep 11
Maroney Dawn ChristinePresidentSep 11 '26Sale12.68122,7071,555,925794,606Sep 11
KAO JOHN EChief Executive OfficerSep 10 '26Sale12.96172,6002,236,447618,166Sep 11
Maroney Dawn ChristinePresidentAug 14 '26Sale14.005,00070,000917,313Aug 18
KAO JOHN EChief Executive OfficerAug 10 '26Sale13.88298,0004,136,776790,766Aug 10
Maroney Dawn ChristinePresidentJul 15 '26Option Exercise9.06152,0681,377,7361,099,381Jul 16
Maroney Dawn ChristinePresidentJul 15 '26Sale20.83177,0683,687,990922,313Jul 16
KAO JOHN EChief Executive OfficerJul 10 '26Sale19.86298,0005,919,3611,088,766Jul 14
KONOWIECKI JOSEPH SEVP, Corporate AffairsJul 01 '26Sale24.0025,000600,0001,103,816Jul 01
KONOWIECKI JOSEPH SEVP, Corporate AffairsJun 26 '26Sale23.0025,000575,0001,128,816Jun 26
KONOWIECKI JOSEPH SEVP, Corporate AffairsJun 18 '26Sale22.0025,000550,0001,153,816Jun 18
Maroney Dawn ChristinePresidentJun 15 '26Sale19.5530,000586,425947,313Jun 15
Kim HyongChief Medical OfficerJun 12 '26Sale19.8635,951713,947331,750Jun 15
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.